New drugs of 1977: Part i
Hussar, D.A.
American Journal of Pharmacy and the Sciences Supporting Public Health 150(1): 14-27
1978
ISSN/ISBN: 0002-9467 PMID: 27987 Document Number: 131088
Document emailed within 1 workday
Related Documents
Wrześniok, D.; Buszman, E.; Matusiński, B. 2003: Drugs ototoxicity. Part II. Loop diuretics, nonsteroidal anti-inflammatory drugs, antineoplastic and antimalarial drugs Wiadomosci Lekarskie 56(7-8): 369-374Wollmann, H.; Patrunky, M. 1981: Stability testing of solid drugs using preferentially thin-layer chromatography and differential thermal analysis. Part 7: the stability of drugs and preparations Die Pharmazie 36(7): 453-456
Lycka, A.; Cizmárik, J. 1987: 15N NMR in analysis of drugs. Part 1. Characterization of some carbamates Die Pharmazie 42(4): 271-272
Pfeifer, S. 1995: Pharmacokinetic drug interactions. Part 3: Drugs P-Z Die Pharmazie 50(5): 307-332
Allen, L.V. 2007: PostScription: Thousands of Unapproved new Drugs are on the U.S. Market, Part 1 International Journal of Pharmaceutical Compounding 11(4): 350-351
Brumback, R.A. 1981: The neuromuscular junction. Part I: physiology and the effects of drugs and toxins American Family Physician 23(1): 188-192
Singh, B.N.; Cho, Y.W.; Kuemmerle, H.P. 1981: Clinical pharmacology of antiarrhythmic drugs: a review and overview, part Ii International Journal of Clinical Pharmacology Therapy and Toxicology 19(5): 185-199
Brill, D.M.; Fozzard, H.A. 1985: Calcium channel blocking drugs. Part II: Clinical applications Comprehensive Therapy 11(10): 67-71
Koetting, J.F. 1977: The use of drugs for behavior modification as it relates to the practice of optometry--Part Ii Journal of the American Optometric Association 48(2): 213-222
Devleeschouwer, M.J.; Akin, A.; Dony, J. 1980: Microbial contamination of drugs--Ecology and antibiotic resistance. Part Ii Journal de Pharmacie de Belgique 35(4): 266-272
Klipa, T.V.; Eremenko, A.A.; Shepelyuk, A.N.; Antonov, I.O. 2015: Pharmacological Neuroprotection in Cardiosurgery (Part 1): Drugs for General Anesthesia Anesteziologiia i Reanimatologiia 60(4): 43-49
Fiegel, G. 1991: Interactions with anabolic steroids. Part 2: Individual drugs, estrogens and glucocorticoids Fortschritte der Medizin 109(32): 661-662
Allen, L.V. 2006: Basics of compounding for hazardous drugs, part 2: regulation and sources of contamination International Journal of Pharmaceutical Compounding 10(6): 446-448
Hopkała, H.; Przyborowski, L. 1989: Determination of drugs containing fluorine with ion-selective electrode. Part 2: Butyrophenones and bis(4-fluorophenyl)butylpiperidines Die Pharmazie 44(1): 65
Tamir, O.; Friedman, N.; Furman-Assaf, S.; Marom, E.; Arieli, M.; Shemer, J. 2010: Counterfeit drugs in Israel and worldwide. Part I: the extent of occurrence and impending threats Harefuah 149(7): 466-469; 479
Duc, C.L. 1976: Antilipidemic drugs. Part 3: on the synthesis of 14C-radiolabelled isopropyl-[4'-chlorobenzoyl)-2-phenoxy-2-methyl]-propionate (LF-178) Arzneimittel-Forschung 26(5): 894-895
Hrbek, J.; Macáková, J.; Komenda, S.; Siroká, A.; Rypka, M. 1985: On acute effects of some drugs on the higher nervous activity in man (the acoustic analyser). Clorotepin (0.5 mg and 1.0 mg), pemoline (100 mg). Part Li Acta Universitatis Palackianae Olomucensis Facultatis Medicae 111: 139-153
Orszulak-Michalak, D. 1995: The influence of selected general anesthetics on pharmacokinetic parameters of some antiarrhythmic drugs in rabbits. Part IV. Lidocaine Acta Poloniae Pharmaceutica 52(4): 315-319
Orszulak-Michalak, D. 1995: The influence of selected general anesthetics on pharmacokinetic parameters of some antiarrhythmic drugs in rabbits. Part II. N-acetylprocainamide Acta Poloniae Pharmaceutica 52(2): 147-151
Orszulak-Michalak, D. 1996: The influence of selected general anesthetics on pharmacokinetic parameters of some antiarrhythmic drugs in rabbits. Part V. Verapamil Acta Poloniae Pharmaceutica 53(1): 57-61